My Dashboard
Fin. Planning
Our Solutions
Stocks
Funds
Invest in the best stock opportunities right now and every time.
Start Systematic Stock Investing ...in less than a minute.
BSE: 524632 | NSE: | Pharmaceuticals & Drugs | Small Cap
1. Is Shukra Pharmaceuticals Ltd a good quality company?
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Shukra Pharmaceuticals Ltd is a below average quality company.
2. Is Shukra Pharmaceuticals Ltd undervalued or overvalued?
The key valuation ratios of Shukra Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
3. Is Shukra Pharmaceuticals Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Shukra Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘValue Creation Index Colour Code Guide ⓘ |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | TTM | |||
| ROCE % ⓘ | -9.1% | -6.3% | -1.1% | 3.4% | 3.5% | 3.4% | 2.3% | -0.2% | 0.7% | 4.2% | - | ||
| Value Creation Index ⓘ | NA | -1.5 | -1.1 | -0.8 | -0.8 | -0.8 | -0.8 | -1.0 | -1.0 | -0.7 | - | ||
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ |
|||||||||||||
| Sales ⓘ | 5.1 | 4.4 | 2.6 | 4.8 | 5.1 | 5.3 | 5.7 | 11.9 | 11.2 | 20.5 | 22 | ||
| YoY Gr. Rt. % | - | -13.3% | -41.8% | 87.2% | 6.4% | 3.9% | 6% | 109.4% | -5.5% | 83% | - | ||
| Adj EPS ⓘ | -0.2 | -1 | -0.2 | 0.7 | 0.7 | 0.7 | 0.6 | -0.1 | 0.2 | 1 | 1 | ||
| YoY Gr. Rt. % | - | NA | NA | NA | 0% | 4.5% | -12.9% | -108.2% | NA | 450% | - | ||
| BVPS (₹) ⓘ | -0.1 | 18.4 | 18.6 | 18.7 | 19.4 | 20 | 20.4 | 20.5 | 20.7 | 21.7 | 23.9 | ||
| Adj Net Profit ⓘ | -1 | -0.8 | -0.2 | 0.5 | 0.5 | 0.5 | 0.5 | 0 | 0.1 | 0.7 | 1 | ||
| Cash Flow from Ops. ⓘ | 10.4 | -3.1 | -2 | 2.7 | -0.3 | 0.8 | 0.3 | 1.2 | 0.5 | 7.8 | - | ||
| Debt/CF from Ops. ⓘ | 1 | -0.1 | -0.6 | 0 | -0.1 | 4.3 | 23.4 | 6.5 | 18.2 | 0.4 | - | ||
CAGR ⓘCAGR Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 Years | 5 Years | 3 Years | 1 Years | |||||||||
| Sales ⓘ | 16.7% | 31.9% | 53.6% | 83% | ||||||||
| Adj EPS ⓘ | NA | 8.1% | 17.5% | 450% | ||||||||
| BVPS ⓘ | 0 | 2.3 | 2.1 | 4.8 | ||||||||
| Share Price | 64.2% | 44.7% | 84.7% | 406.6% | ||||||||
Key Financial Parameters ⓘPerformance Ratio Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | TTM | ||
| Return on Equity % ⓘ | -193.3 | -11.3 | -1.1 | 3.6 | 3.5 | 3.6 | 3 | -0.2 | 0.9 | 4.7 | 4.4 | |
| Op. Profit Mgn % ⓘ | 10.1 | -2.1 | -9.6 | 24.5 | 28.5 | 30.2 | 29.1 | 13 | 12.9 | 14.1 | 15.2 | |
| Net Profit Mgn % ⓘ | -19.7 | -17 | -6 | 10.4 | 9.8 | 9.9 | 8.2 | -0.3 | 1.2 | 3.6 | 5 | |
| Debt to Equity ⓘ | -23.5 | 0 | 0.1 | 0 | 0 | 0.2 | 0.4 | 0.5 | 0.6 | 0.2 | 0.1 | |
| Working Cap Days ⓘ | 601 | 390 | 879 | 392 | 379 | 467 | 526 | 334 | 487 | 277 | 273 | |
| Cash Conv. Cycle ⓘ | 179 | 90 | 165 | 75 | 64 | 31 | 40 | 39 | 132 | 54 | 31 | |
Return on Equity has increased versus last 3 years average to 4.40%
Sales growth is growing at healthy rate in last 3 years 53.55%
Net Profit is growing at healthy rate in last 3 years 17.52%
Sales growth is good in last 4 quarters at 53.06%
No data to display
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 1 | - |
| TTM Sales (₹ Cr.) | 22.1 | - |
| BVPS (₹.) ⓘ | 23.9 | - |
| Reserves (₹ Cr.) ⓘ | 15 | - |
| P/BV ⓘ | 2.92 | - |
| PE ⓘ | 69.53 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 11.14 / 69.60 |
| All Time Low / High (₹) | 0.09 / 66.30 |
| Market Cap (₹ Cr.) | 76.3 |
| Equity (₹ Cr.) | 11 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 33.7 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Shukra Pharmaceuticals is an ambitious organisation with a deep rooted focus on sustainability with its impressive range of solutions. The company is committed to deliver excellence across National & Global markets. It is a public limited organisation with globally acclaimed manufacturing facilities.
The company is strongly committed to its values that guide it - The Shukra Group in serving the needs of its stakeholders including customers, suppliers, employees and other interest groups by large. Shukra stands for uncompromising quality and efficiency to deliver proven solutions delivered by passionate and motivated team of individuals.
The company boasts fully integrated structure for manufacturing general formulations like Tablet, Capsules and small volume parenteral since 2017. Along with internationally accredited facilities it invests in people.
The company has embarked upon its ambitious journey in the field of Pharamaceutical (date of inception) with a fully integrated plant in Rakanpor in Kalol, Gandhinagar - Gujarat. Since then, there was no looking back, within a short span of (years) the company has come a long way in making its mark in the sector.
The company has now developed an internationally accredited Laboratory in Ahmedabad where each product and solutions are developed under stringent quality processes.
Business area of the company
The company is engaged in the business of manufacturing and trading of pharmaceuticals Products, laboratory testing.
Download APP
